[HTML][HTML] Biobanks for life sciences and personalized medicine: importance of standardization, biosafety, biosecurity, and data management

H Müller, G Dagher, M Loibner, C Stumptner… - Current Opinion in …, 2020 - Elsevier
Biological samples such as tissues, blood and other body fluids, plants or seeds, prokaryotic
and eukaryotic cells or isolated biomolecules as well as associated data are the essential …

[HTML][HTML] Challenges in mapping European rare disease databases, relevant for ML-based screening technologies in terms of organizational, FAIR and legal principles …

R Raycheva, K Kostadinov, E Mitova… - Frontiers in Public …, 2023 - frontiersin.org
Background Given the increased availability of data sources such as hospital information
systems, electronic health records, and health-related registries, a novel approach is …

[HTML][HTML] MIRACUM: medical informatics in research and care in university medicine

HU Prokosch, T Acker, J Bernarding… - … of information in …, 2018 - thieme-connect.com
Introduction: This article is part of the Focus Theme of Methods of Information in Medicine on
the German Medical Informatics Initiative. Similar to other large international data sharing …

[HTML][HTML] Share and protect our health data: an evidence based approach to rare disease patients' perspectives on data sharing and data protection-quantitative survey …

S Courbier, R Dimond, V Bros-Facer - Orphanet journal of rare diseases, 2019 - Springer
Background The needs and benefits of sharing health data to advance scientific research
and improve clinical benefits have been well documented in recent years, specifically in the …

[HTML][HTML] Orphan medicine incentives: how to address the unmet needs of rare disease patients by optimizing the European orphan medicinal product landscape …

A Aartsma-Rus, M Dooms, Y Le Cam - Frontiers in pharmacology, 2021 - frontiersin.org
Today policy makers face the challenge to devise a policy framework that improves orphan
medicinal product (OMP) development by creating incentives to deliver treatments where …

Extending the minimum information about biobank data sharing terminology to describe samples, sample donors, and events

N Eklund, NH Andrianarisoa… - Biopreservation and …, 2020 - liebertpub.com
Introduction: The Minimum Information About BIobank data Sharing (MIABIS) was initiated in
2012. MIABIS aims to create a common biobank terminology to facilitate data sharing in …

[HTML][HTML] RD-Connect, NeurOmics and EURenOmics: collaborative European initiative for rare diseases

H Lochmüller, DM Badowska, R Thompson… - European Journal of …, 2018 - nature.com
Although individually uncommon, rare diseases (RDs) collectively affect 6–8% of the
population. The unmet need of the rare disease community was recognized by the …

[HTML][HTML] Resources and tools for rare disease variant interpretation

L Licata, A Via, P Turina, G Babbi… - Frontiers in Molecular …, 2023 - frontiersin.org
Collectively, rare genetic disorders affect a substantial portion of the world's population. In
most cases, those affected face difficulties in receiving a clinical diagnosis and genetic …

[HTML][HTML] The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage

A Ambrosini, D Calabrese, FM Avato, F Catania… - Orphanet Journal of …, 2018 - Springer
Background The worldwide landscape of patient registries in the neuromuscular disease
(NMD) field has significantly changed in the last 10 years, with the international TREAT …

[HTML][HTML] Data collection on rare bone and mineral conditions in Europe: The landscape of registries and databases

ALP Zurita, C Grasemann, M Boarini… - European Journal of …, 2023 - Elsevier
Background knowledge on the natural history of rare diseases is necessary to improve
outcomes. Disease registries may play a key role in covering these unmet needs in the rare …